- Report
- March 2026
- 271 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- March 2026
- 280 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- March 2026
- 227 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 180 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 193 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 190 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 150 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 202 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 166 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 185 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 184 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 169 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 155 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 190 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 161 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 162 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 211 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 175 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 196 Pages
Global
From €4324EUR$4,850USD£3,735GBP
- Report
- February 2026
- 188 Pages
Global
From €4324EUR$4,850USD£3,735GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more